Total Artificial Heart: A Therapy That Fails to Gain Traction
A retrospective study analyzing the evolution of all SynCardia® total artificial heart (TAH) implants as a bridge to transplantation in the United States from 2005 to 2018.
A retrospective study analyzing the evolution of all SynCardia® total artificial heart (TAH) implants as a bridge to transplantation in the United States from 2005 to 2018.
The EARLY-UNLOAD study is a single-center, prospective clinical trial comparing early initiation of routine LV unloading in cardiogenic shock (CS) patients supported by veno-arterial extracorporeal membrane oxygenation (VA-ECMO) against conventional management.
This pioneering retrospective study examines the association between the Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification and morbidity-mortality rates in cardiac surgery patients.
A retrospective analysis of the United Network for Organ Sharing (UNOS) database was conducted in the United States, comparing septuagenarians receiving donor hearts from individuals younger than 50 with those receiving from donors aged 50 and older, employing propensity score matching.
Expert analysis by Dr. Mario Castaño, coordinator of our society’s ECMO-COVID registry, on the temporal evolution of in-hospital survival of COVID-19 patients requiring ECMO support in the United States.
This article analyzes the results of the Spanish Heart Transplant Registry for 2022, including trends since 2013.
An expert commentary by Dr. J. Cuenca on the past, present, and future of prioritization criteria for heart transplantation in Spain, recently updated in April 2023.
A position paper by the European Society of Heart Failure, the Association of Acute Cardiovascular Care, and the European Association for Percutaneous Cardiovascular Interventions addresses the challenges in managing acute heart failure (AHF) with associated valvular heart disease (VHD).
This retrospective study analyzes critical echocardiographic findings associated with poor prognosis in patients on veno-arterial extracorporeal membrane oxygenation (VA ECMO) for cardiogenic shock.
This study offers the first detailed analysis of the Spanish registry for long-term ventricular assist devices (REGALAD), encompassing all patients who received these devices in Spain from 2007 to 2020.